Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Larimar Therapeutics, Inc.

NASDAQ: LRMR · Life Sciences · 10 alerts · CIK 1374690

Share price
$3.00Close, Nov 16
Market cap
$314M
Shares outstanding
104.63MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Larimar Therapeutics, Inc. filings on SEC EDGAR ↗

4:07 PM ET 8-K
Executive Compensation

Larimar Therapeutics Executive Compensation

Larimar Therapeutics appointed John B. Harlow, Jr. as President and Chief Operating Officer, effective September 29, 2026. His compensation package includes an initial base salary of $560,000, a $35,000 signing bonus, and a target annual bonus of 40% of his base salary. The agreement also provides for severance benefits including nine months of base salary and COBRA coverage in the event of termination without cause.

Counterparty
John B. Harlow, Jr.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.